News

Oral steroid dose, duration affect diabetes risk for people with RA

Posted on: 20/12/2015 - 20:06

People with rheumatoid arthritis who take oral glucocorticoids have an increased risk of diabetes, the magnitude of which is dependent on dose and treatment duration, based on an analysis of two...

Field of Interest: Rheumatology

Type: News Item

Have the conversation early: research proxies in Alzheimer’s disease

Posted on: 19/12/2015 - 17:41

Many patients with Alzheimer’s disease can still identify a trusted individual to make decisions about participation in research, even when their cognitive abilities have declined to the point that...

Field of Interest: Geriatrics

Type: News Item

More funding, new programs headline NIA’s 2015 Alzheimer’s report

Posted on: 19/12/2015 - 15:45

While 2015 might not have been the year of the blockbuster Alzheimer’s drug, it did lay a few more paving stones on the road to understanding the disease. Federal funding boosts, new-generation...

Field of Interest: Geriatrics

Type: News Item

Second dose of herpes zoster vaccine beneficial to seniors

Posted on: 19/12/2015 - 13:45

The herpes zoster vaccine should be administered earlier rather than later in order to achieve optimal immune response, but an additional booster shot for individuals 70 years or older is also...

Field of Interest: Geriatrics

Type: News Item

Cancer incidence higher in men, blacks

Posted on: 18/12/2015 - 19:06

The overall incidence of invasive cancer in the United States was 440.3 per 100,000 persons for 2012, the Centers for Disease Control and Prevention reported Dec. 17. More than 1.5 million such...

Field of Interest: Oncology

Type: News Item

Neratinib shows consistent breast cancer benefit at 3 years

Posted on: 18/12/2015 - 19:05

SAN ANTONIO – The investigational oral tyrosine kinase inhibitor neratinib showed continued benefit in terms of reduced invasive disease-free survival at 3 years of follow-up in women with...

Field of Interest: Pulmonology

Type: News Item

Neratinib shows consistent breast cancer benefit at 3 years

Posted on: 18/12/2015 - 19:05

SAN ANTONIO – The investigational oral tyrosine kinase inhibitor neratinib showed continued benefit in terms of reduced invasive disease-free survival at 3 years of follow-up in women with...

Field of Interest: Oncology

Type: News Item

FDA proposes ban on indoor tanning for minors

Posted on: 18/12/2015 - 17:42

The Food and Drug Administration wants to prohibit indoor tanning for minors and is seeking stricter regulations to enhance the safety of indoor tanning and use of sunlamp products for all...

Field of Interest: Dermatology

Type: News Item

Detailed – not global – tests predict Alzheimer’s progression rates

Posted on: 18/12/2015 - 15:07

Patients with Alzheimer’s disease (AD) who performed poorly on early cognitive tests seemed to progress more rapidly than those with less baseline impairment, a study showed. Age was also an...

Field of Interest: Geriatrics

Type: News Item

Beta-blocker prevents trastuzumab-related LVEF drop

Posted on: 17/12/2015 - 18:49

SAN ANTONIO – Prophylactic beta-blockade with bisoprolol during adjuvant trastuzumab therapy for HER2-positive breast cancer prevented trastuzumab-induced decline in left ventricular ejection...

Field of Interest: Oncology

Type: News Item

« first
‹ previous
…
26
27
28
29
30
31
32
33
34
…
next ›
last »

Newsletters

Stay informed on our latest news!

You are here

Newsletters

Latest Newsletters